PDF herunterladen
Klin Padiatr 2025; 237(03): e3
DOI: 10.1055/a-2623-7760
Erratum

Correction: GPOH Guidelines for Diagnosis and First-line Treatment of Patients with Neuroblastic Tumors, update 2025

Erratum: GPOH-Leitlinien für die Diagnose und Erstlinien-Behandlung von Patienten mit neuroblastischen Tumoren, update 2025

Autor*innen

  • Thorsten Simon 

    1   Pediatric Oncology and Hematology, University of Cologne, Cologne, Germany

  • Theresa Thole

    2   Pediatric Oncology and Hematology, Charité University Hospital Berlin, Berlin, Germany

  • Sveva Castelli

    2   Pediatric Oncology and Hematology, Charité University Hospital Berlin, Berlin, Germany

  • Beate Timmermann

    3   Westgerman Protontherapycenter Essen, University of Duisburg-Essen, Duisburg, Germany

  • Danny Jazmati

    4   Department of Radiation Oncology, Heinrich Heine University Düsseldorf, Dusseldorf, Germany

  • Rudolf Schwarz

    5   Department for Radiotherapy, UKE, Hamburg, Germany

  • Jörg Fuchs

    6   Pediatric Surgery and Urology, University of Tübingen, Tübingen, Germany

  • Steven Warmann

    7   Department of Pediatric Surgery, Charité University Hospital Berlin, Berlin, Germany

  • Jochen Hubertus

    8   Department of Pediatric Surgery, Marien-Hospital Witten, Witten, Germany

  • Matthias Schmidt

    9   Nuclear Medicine, University of Cologne, Cologne, Germany

  • Julian Rogasch

    10   Nuclear Medicine, Charité University Hospital Berlin, Berlin, Germany

  • Friederike Körber

    11   Institut und Poliklinik für Radiologische Diagnostik, Kinderradiologie, University of Cologne, Cologne, Germany

  • Christian Vokuhl

    12   Pediatric Pathology, Institute for Pathology, University of Bonn, Bonn, Germany

  • Jürgen Schäfer

    13   Diagnostic and Interventional Radiology, University of Tübingen, Tübingen, Germany

  • Johannes Hubertus Schulte

    14   Pediatric Oncology and Hematology, University of Tübingen, Tübingen, Germany

  • Hedwig Deubzer

    2   Pediatric Oncology and Hematology, Charité University Hospital Berlin, Berlin, Germany

  • Carolina Rosswog

    1   Pediatric Oncology and Hematology, University of Cologne, Cologne, Germany
    15   Experimental Pediatric Oncology, University of Cologne, Cologne, Germany

  • Matthias Fischer

    1   Pediatric Oncology and Hematology, University of Cologne, Cologne, Germany
    15   Experimental Pediatric Oncology, University of Cologne, Cologne, Germany

  • Peter Lang

    14   Pediatric Oncology and Hematology, University of Tübingen, Tübingen, Germany

  • Thorsten Langer

    16   Childrens’ Hospital, University Hospital Schleswig-Holstein Lübeck Campus, Lübeck, Germany

  • Kathy Astrahantseff

    2   Pediatric Oncology and Hematology, Charité University Hospital Berlin, Berlin, Germany

  • Holger Lode

    17   Pediatric Oncology and Hematology, University of Greifswald, Greifswald, Germany

  • Barbara Hero

    1   Pediatric Oncology and Hematology, University of Cologne, Cologne, Germany

  • Angelika Eggert

    2   Pediatric Oncology and Hematology, Charité University Hospital Berlin, Berlin, Germany
Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Originalartikel zu diesem Erratum:

GPOH Guidelines for Diagnosis and First-line Treatment of Patients with Neuroblastic Tumors, update 2025Klin Padiatr 2025; 237(03): 117-140
DOI: 10.1055/a-2556-4302

CORRECTION

Simon T, Thole T, Castelli S et al. GPOH Guidelines for Diagnosis and First-line Treatment of Patients with Neuroblastic Tumors, update 2025. Klin Padiatr 2025; 237:117– 140

DOI 10.1055/a-2556-4302

Table 5 has been corrected.



Publikationsverlauf

Artikel online veröffentlicht:
05. Juni 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany